Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Regen BioPharma Inc
| Metric | Regen BioPharma Inc RGBPHealthcare |
|---|---|
| Quality Score | 45 / 100 |
| Revenue (latest) | $236,561 |
| Net income (latest) | −$1M |
| Operating margin | −143.1% |
| Net margin | −538.8% |
| Return on equity | 20.3% |
| Return on assets | −464.1% |
| Return on capital (ROCE) | — |
| Debt / equity | — |
| Revenue growth (YoY) | 0.0% |
| Altman Z″ (distress) | -416.82 |
| Accruals / assets | −324.4% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.